Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Gets Patent for Genomic Database Agents

Premium

W

OBURN, Mass.--AlphaGene, an integrated genomics company, said it has received a patent for agents used in genomic databases from the US Patent and Trademark Office. The patent covers the use of agents that implement continuous, selective database updates to proceed asynchronously with respect to the addition of new data into the database. These agents keep large and dynamic databases well annotated and up-to-date, while allowing users to keep long-running searches alive for entries meeting certain annotation criteria.

Changes in methods of annotation or amount of data in the databases do not limit users who continue using and researching the databases. The patented agents "sense" the status of the database entries while processing and updating the data and update only the pertinent criteria and annotations in the database. The remaining entries are left untouched.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.